Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Am Heart J
    November 2024
  1. SALAM A, Sani MU, Ogah OS, Huffman MD, et al
    deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trial.
    Am Heart J. 2024;277:66-75.
    >> Share

    September 2024
  2. KERCHEVAL JB, Narcisse DI, Nguyen M, Rao SV, et al
    Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study.
    Am Heart J. 2024;275:183-190.
    >> Share

    August 2024
  3. KIM CW, Haji M, Lopes VV, Halladay C, et al
    Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension.
    Am Heart J. 2024 Aug 29:S0002-8703(24)00204-7. doi: 10.1016/j.ahj.2024.
    >> Share

  4. CHEN MT, Vollmer BL, Blyler CA, Cameron NA, et al
    Antihypertensive Medication Prescription Dispensation Among Pregnant Women in the United States: A Cohort Study.
    Am Heart J. 2024 Aug 21:S0002-8703(24)00205-9. doi: 10.1016/j.ahj.2024.
    >> Share

    July 2024
  5. POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al
    Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024.
    >> Share

    June 2024
  6. METLOCK FE, Kwapong YA, Evans C, Ouyang P, et al
    Design and Rationale of the Social Determinants of the Risk of Hypertension in Women of Reproductive Age (SAFE HEART) Study: An American Heart Association Research Goes Red Initiative.
    Am Heart J. 2024 Jun 9:S0002-8703(24)00138-8. doi: 10.1016/j.ahj.2024.
    >> Share

    May 2024
  7. COMMODORE-MENSAH Y, Chen Y, Ogungbe O, Liu X, et al
    Design and Rationale of the Cardiometabolic Health Program Linked with Community Health Workers and Mobile Health Telemonitoring to Reduce Health DisparitieS (LINKED-HEARTS) Program.
    Am Heart J. 2024 May 15:S0002-8703(24)00123-6. doi: 10.1016/j.ahj.2024.
    >> Share

    April 2024
  8. DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
    Early Postpartum Blood Pressure Screening is Associated with Increased Detection of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
    Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
    >> Share

  9. ZHANG H, Huo X, Ren L, Lu J, et al
    Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: a cluster randomized controlled trial for hypertension management in primary care.
    Am Heart J. 2024 Apr 2:S0002-8703(24)00079-6. doi: 10.1016/j.ahj.2024.
    >> Share

    March 2024
  10. MILLER HE, Tierney S, Stefanick ML, Mayo JA, et al
    Vascular health years after a hypertensive disorder of pregnancy: The EPOCH Study.
    Am Heart J. 2024 Mar 12:S0002-8703(24)00055-3. doi: 10.1016/j.ahj.2024.
    >> Share

  11. HAMO CE, Schlamp F, Drenkova K, Jindal M, et al
    Burden of cardiometabolic risk factors and vascular health.
    Am Heart J. 2024;269:201-204.
    >> Share

    February 2024
  12. MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al
    Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies.
    Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024.
    >> Share

    December 2023
  13. CHITTURI KR, Haberman D, Wermers JP, Waksman R, et al
    Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the Symplicity Spyral Renal Denervation System.
    Am Heart J. 2023 Dec 19:S0002-8703(23)00350-2. doi: 10.1016/j.ahj.2023.
    >> Share

    November 2023
  14. KIM M, Choi JH, Kim HK, Kim HL, et al
    Effects of Intensive Blood Pressure Control on Left Ventricular Hypertrophy in Aortic Valve Disease.
    Am Heart J. 2023 Nov 23:S0002-8703(23)00321-6. doi: 10.1016/j.ahj.2023.
    >> Share

  15. HAFF N, Sreedhara SK, Wood W, Yom-Tov E, et al
    Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial.
    Am Heart J. 2023 Nov 13:S0002-8703(23)00313-7. doi: 10.1016/j.ahj.2023.
    >> Share

  16. GNANENTHIRAN SR, Tan I, Atkins ER, Avolio A, et al
    Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol.
    Am Heart J. 2023;265:50-58.
    >> Share

    June 2023
  17. ZHAO X, Chen Y, Yang G, Li X, et al
    Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
    Am Heart J. 2023 Jun 3:S0002-8703(23)00142-4. doi: 10.1016/j.ahj.2023.
    >> Share

    April 2023
  18. DA FONSECA SF, Pinho Ribeiro AL, Rodrigues Cimini CC, de Castro Soares TB, et al
    Scale up of implementation of a multidimensional intervention to enhance hypertension and diabetes care at the primary care setting: a protocol for a cluster-randomized study in Brazil.
    Am Heart J. 2023 Apr 10:S0002-8703(23)00092-3. doi: 10.1016/j.ahj.2023.
    >> Share

  19. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    >> Share

  20. FANAROFF AC, Coratti S, Halaby R, Sanghavi M, et al
    Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial.
    Am Heart J. 2023;258:85-95.
    >> Share

    January 2023
  21. WU Q, Ye Z, Zhou C, Liu M, et al
    A U-shaped association between dietary phosphorus intake and new-onset hypertension: A nationwide cohort study in China.
    Am Heart J. 2023 Jan 20:S0002-8703(23)00020-0. doi: 10.1016/j.ahj.2023.
    >> Share

  22. GREEN MD, Dalmage MR, Lusk JB, Kadhim EF, et al
    Public Reporting of Black Participation in Anti-Hypertensive Drug Clinical Trials.
    Am Heart J. 2023 Jan 11:S0002-8703(23)00001-7. doi: 10.1016/j.ahj.2023.
    >> Share

  23. LAUFFENBURGER JC, Khatib R, Siddiqi A, Albert MA, et al
    Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design.
    Am Heart J. 2023;255:12-21.
    >> Share

    December 2022
  24. BENINCASA G, Napoli C, Loscalzo J, Maron BA, et al
    Pursuing Functional Biomarkers in Complex Disease: Focus on Pulmonary Arterial Hypertension.
    Am Heart J. 2022 Dec 21:S0002-8703(22)00330-1. doi: 10.1016/j.ahj.2022.
    >> Share

  25. LIU J, Wang B, Li Y, Yan X, et al
    Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
    >> Share

    October 2022
  26. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
    On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
    >> Share

    September 2022
  27. BALDRIDGE AS, Huffman MD, Lazar D, Abbas H, et al
    Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA): Rationale and Design for a Randomized Controlled Trial.
    Am Heart J. 2022 Sep 15. pii: S0002-8703(22)00189.
    >> Share

    August 2022
  28. WANG SY, Hanna JM, Gongal P, Onuma O, et al
    Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial.
    Am Heart J. 2022 Aug 3. pii: S0002-8703(22)00157.
    >> Share

    July 2022
  29. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    >> Share

  30. MACEDO AVS, de Barros E Silva PGM, de Paula TC, Moll-Bernardes RJ, et al
    Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial.
    Am Heart J. 2022;249:86-97.
    >> Share

    June 2022
  31. MAGANJA D, Trieu K, Reading M, Huang L, et al
    Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping (OGS) randomised trial.
    Am Heart J. 2022 Jun 28. pii: S0002-8703(22)00131.
    >> Share

    May 2022
  32. HENDRIKS PM, van de Groep LD, Veen KM, van Thor MCJ, et al
    Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00093.
    >> Share

  33. SHAH NP, Clare RM, Chiswell K, Navar AM, et al
    Trends of blood pressure control in the U.S. during the COVID-19 pandemic.
    Am Heart J. 2022;247:15-23.
    >> Share

    April 2022
  34. KAZE AD, Gao X, Musani SK, Bidulescu A, et al
    Association of plasma endothelin-1 with blood pressure progression among Blacks: The Jackson Heart Study.
    Am Heart J. 2022;246:144-151.
    >> Share

    October 2021
  35. ZHEUTLIN AR, Derington CG, King JB, Berchie RO, et al
    Factors Associated with Antihypertensive Monotherapy Among US Adults with Treated Hypertension and Uncontrolled Blood Pressure Overall and by Race/Ethnicity, NHANES 2013-2018.
    Am Heart J. 2021 Oct 15. pii: S0002-8703(21)00436.
    >> Share

  36. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    >> Share

  37. SANDHU AT, Kohsaka S, Lin S, Woo CY, et al
    Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
    Am Heart J. 2021;240:46-57.
    >> Share

    July 2021
  38. EGBE AC, Miranda WR, Connolly HM, Borlaug BA, et al
    Coarctation of Aorta is Associated with Left Ventricular Stiffness, Left Atrial Dysfunction and Pulmonary Hypertension.
    Am Heart J. 2021 Jul 18. pii: S0002-8703(21)00184.
    >> Share

    May 2021
  39. MAHFOUD F, Weber M, Schmieder RE, Lobo MD, et al
    Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
    Am Heart J. 2021 May 27. pii: S0002-8703(21)00144.
    >> Share

  40. STEVENS BR, Pepine CJ, Richards EM, Kim S, et al
    Depressive-hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
    Am Heart J. 2021 May 10:100540. doi: 10.1016/j.ahj.2021.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016